Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases

Pharmacology and Therapeutics

Volumn 138, Issue 3, 2013, Pages 441-451

  Li, Jing ^a,b   Wang, Xiaohui ^a   Zhang, Fengchun ^b   Yin, Hang ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Autoimmune diseases; Drug discovery; Inflammation Small molecule modulator; Toll like receptor

Indexed keywords

6 CHLORO 7 METHOXY 8 (2 METHYLNICOTINAMIDO) BETA CARBOLINE; ANTIBODY; DELMITIDE; DNA; DOUBLE STRANDED DNA; FIBRINOGEN; HEAT SHOCK PROTEIN 70; I KAPPA B KINASE; I KAPPA B KINASE 2; I KAPPA B KINASE INHIBITOR; IMIQUIMOD; ML 120 B; MYELOID DIFFERENTIATION FACTOR 88; OLIGODEOXYRIBONUCLEOTIDE; PHA 408; RNA; SMALL MOLECULE TRANSPORT AGENT; ST 2825; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZYMOSAN;

APOPTOSIS; AUTOIMMUNE CONNECTIVE TISSUE DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL STRAIN; CONNECTIVE TISSUE DISEASE; DENDRITIC CELL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ENTERITIS; FUNGUS; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VIRUS STRAIN;

ANIMALS; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; HUMANS; IMMUNOLOGIC FACTORS; TOLL-LIKE RECEPTORS;

EID: 84877577557     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.03.003     Document Type: Review

References (169)

1. C. Abarientos, K. Sperber, D.L. Shapiro, W.S. Aronow, C.P. Chao, and J.Y. Ash Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy Expert Opin Drug Saf 10 2011 705 714
2. S. Abdollahi-Roodsaz, L.A. Joosten, M.I. Koenders, I. Devesa, M.F. Roelofs, and T.R. Radstake Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis J Clin Invest 118 2008 205 216
3. S. Abdollahi-Roodsaz, L.A. Joosten, M.F. Roelofs, T.R. Radstake, G. Matera, and C. Popa Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis Arthritis Rheum 56 2007 2957 2967
4. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511
5. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738
6. A.O. Aliprantis, R.B. Yang, M.R. Mark, S. Suggett, B. Devaux, and J.D. Radolf Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2 Science 285 1999 736 739
7. Y. Arnson, Y. Shoenfeld, and H. Amital Effects of tobacco smoke on immunity, inflammation and autoimmunity J Autoimmun 34 2010 J258 J265
8. F. Arslan, J.H. Houtgraaf, B. Keogh, K. Kazemi, R. de Jong, and W.J. McCormack Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs Circ Cardiovasc Interv 5 2012 279 287
9. A. Asea, M. Rehli, E. Kabingu, J.A. Boch, O. Bare, and P.E. Auron Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4 J Biol Chem 277 2002 15028 15034
10. S. Assassi, M.D. Mayes, F.C. Arnett, P. Gourh, S.K. Agarwal, and T.A. McNearney Systemic sclerosis and lupus: points in an interferon-mediated continuum Arthritis Rheum 62 2010 589 598
11. S. Babu, C.P. Blauvelt, V. Kumaraswami, and T.B. Nutman Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection J Immunol 176 2006 3885 3889
12. E.C. Baechler, F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, and K.J. Espe Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proc Natl Acad Sci USA 100 2003 2610 2615
13. A.S. Baldwin Regulation of cell death and autophagy by IKK and NF-kappaB: critical mechanisms in immune function and cancer Immunol Rev 246 2012 327 345
14. F.J. Barrat, T. Meeker, J. Gregorio, J.H. Chan, S. Uematsu, and S. Akira Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus J Exp Med 202 2005 1131 1139
15. A.A. Bengtsson, G. Sturfelt, L. Truedsson, J. Blomberg, G. Alm, and H. Vallin Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies Lupus 9 2000 664 671
16. M.W. Boule, C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I.R. Rifkin Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes J Exp Med 199 2004 1631 1640
17. F. Brentano, O. Schorr, R.E. Gay, S. Gay, and D. Kyburz RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3 Arthritis Rheum 52 2005 2656 2665
18. Y. Bulut, E. Faure, L. Thomas, H. Karahashi, K.S. Michelsen, and O. Equils Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway J Immunol 168 2002 1435 1440
19. F. Capolunghi, M.M. Rosado, S. Cascioli, E. Girolami, S. Bordasco, and M. Vivarelli Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients Rheumatology (Oxford) 49 2010 2281 2289
20. S. Carsons Sjögren's syndrome G.S. Firestein, R.C. Budd, E.D. Harris Jr. I.B. McInnes, S. Ruddy, J.S. Sergent, Kelley's Textbook of Rheumatology 8th ed. 2008
21. J. Castiblanco, D.C. Varela, N. Castano-Rodriguez, A. Rojas-Villarraga, M.E. Hincapie, and J.M. Anaya TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus Infect Genet Evol 8 2008 541 544
22. H.C. Chai, M.E. Phipps, and K.H. Chua Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview Clin Dev Immunol 2012 2012 963730
23. S.R. Christensen, M. Kashgarian, L. Alexopoulou, R.A. Flavell, S. Akira, and M.J. Shlomchik Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus J Exp Med 202 2005 321 331
24. S.R. Christensen, J. Shupe, K. Nickerson, M. Kashgarian, R.A. Flavell, and M.J. Shlomchik Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus Immunity 25 2006 417 428
25. P.S. Coelho, A. Klein, A. Talvani, S.F. Coutinho, O. Takeuchi, and S. Akira Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-gamma-primed-macrophages J Leukoc Biol 71 2002 837 844
26. O. de Bouteiller, E. Merck, U.A. Hasan, S. Hubac, B. Benguigui, and G. Trinchieri Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH J Biol Chem 280 2005 38133 38145
27. U.S. Deshmukh, S.R. Nandula, P.R. Thimmalapura, Y.M. Scindia, and H. Bagavant Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function J Oral Pathol Med 38 2009 42 47
28. C.G. DeVry, M. Valdez, L. Gao, J. Wang, K. Kotsch, and H.D. Volk RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis J Neuroimmunol 152 2004 33 43
29. B. Diamond, and P.E. Lipsky Harrison's Principles of Internal Medicine. Chapter 312. Autoimmunity and Autoimmune Diseases A.S. Fauci, D.L. Kasper, D.L. Longo, E. Braunwald, S.L. Hauser, J.L. Jameson, J. Loscalzo, 17th ed. 2008
30. S.S. Diebold, T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA Science 303 2004 1529 1531
31. L. Dong, S. Ito, K.J. Ishii, and D.M. Klinman Suppressive oligonucleotides protect against collagen-induced arthritis in mice Arthritis Rheum 50 2004 1686 1689
32. L. Dong, S. Ito, K.J. Ishii, and D.M. Klinman Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice Arthritis Rheum 52 2005 651 658
33. T. Dorner Therapy: hydroxychloroquine in SLE: old drug, new perspectives Nat Rev Rheumatol 6 2010 10 11
34. E. Elass, L. Aubry, M. Masson, A. Denys, Y. Guerardel, and E. Maes Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism Infect Immun 73 2005 7064 7068
35. M.L. Eloranta, T. Lovgren, D. Finke, L. Mathsson, J. Ronnelid, and B. Kastner Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells Arthritis Rheum 60 2009 2418 2427
36. E.S. Emamian, J.M. Leon, C.J. Lessard, M. Grandits, E.C. Baechler, and P.M. Gaffney Peripheral blood gene expression profiling in Sjogren's syndrome Genes Immun 10 2009 285 296
37. C. Erridge, C.M. Spickett, and D.J. Webb Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2 Cardiovasc Res 73 2007 181 189
38. G.A. Farina, M.R. York, M. Di Marzio, C.A. Collins, S. Meller, and B. Homey Poly(I:C) drives type I IFN- and TGFbeta-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis J Invest Dermatol 130 2010 2583 2593
39. G.S. Firestein Etiology and pathogenesis of rheumatoid arthritis G.S. Firestein, R.C. Budd, E.D. Harris Jr. I.B. McInnes, S. Ruddy, J.S. Sergent, Kelley's Textbook of Rheumatology 8th ed. 2008
40. C. Foulquier, M. Sebbag, C. Clavel, S. Chapuy-Regaud, R. Al Badine, and M.C. Mechin Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation Arthritis Rheum 56 2007 3541 3553
41. D.E. Furst Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis Clin Ther 26 2004 1960 1975
42. M.C. Genovese Treatment of rheumatoid arthritis G.S. Firestein, R.C. Budd, E.D. Harris Jr. I.B. McInnes, S. Ruddy, J.S. Sergent, Kelley's Textbook of Rheumatology 8th ed. 2008
43. R.J. Gibbard, P.J. Morley, and N.J. Gay Conserved features in the extracellular domain of human Toll-like receptor 8 are essential for pH-dependent signaling J Biol Chem 281 2006 27503 27511
44. J.E. Gottenberg, N. Cagnard, C. Lucchesi, F. Letourneur, S. Mistou, and T. Lazure Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome Proc Natl Acad Sci USA 103 2006 2770 2775
45. R.R. Graham, C.D. Langefeld, P.M. Gaffney, W.A. Ortmann, S.A. Selby, and E.C. Baechler Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus Arthritis Res 3 2001 299 305
46. T. Guerrier, L. Le Pottier, V. Devauchelle, J.O. Pers, C. Jamin, and P. Youinou Role of Toll-like Receptors in Primary Sjogren's Syndrome with A Special Emphasis on B-cell Maturation Within Exocrine Tissues 2012 J Autoimmun
47. M. Gururajan, J. Jacob, and B. Pulendran Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets PLoS One 2 2007 e863
48. H. Hacker, H. Mischak, T. Miethke, S. Liptay, R. Schmid, and T. Sparwasser CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation EMBO J 17 1998 6230 6240
49. A.M. Hajjar, D.S. O'Mahony, A. Ozinsky, D.M. Underhill, A. Aderem, and S.J. Klebanoff Cutting edge: functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin J Immunol 166 2001 15 19
50. L. Hang, J.H. Slack, C. Amundson, S. Izui, A.N. Theofilopoulos, and F.J. Dixon Induction of murine autoimmune disease by chronic polyclonal B cell activation J Exp Med 157 1983 874 883
51. E.D. Harris Jr.; and G.S. Firestein Clinical features of rheumatoid arthritis G.S. Firestein, R.C. Budd, E.D. Harris Jr. I.B. McInnes, S. Ruddy, J.S. Sergent, Kelley's Textbook of Rheumatology 8th ed. 2008
52. T.R. Hawn, H. Wu, J.M. Grossman, B.H. Hahn, B.P. Tsao, and A. Aderem A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus Proc Natl Acad Sci USA 102 2005 10593 10597
53. F. Hayashi, K.D. Smith, A. Ozinsky, T.R. Hawn, E.C. Yi, and D.R. Goodlett The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 410 2001 1099 1103
54. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, and S. Akira Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8 Science 303 2004 1526 1529
55. H. Hemmi, T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, and K. Hoshino Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 3 2002 196 200
56. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
57. M. Herrmann, R.E. Voll, O.M. Zoller, M. Hagenhofer, B.B. Ponner, and J.R. Kalden Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus Arthritis Rheum 41 1998 1241 1250
58. M. Hirschfeld, J.J. Weis, V. Toshchakov, C.A. Salkowski, M.J. Cody, and D.C. Ward Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages Infect Immun 69 2001 1477 1482
59. K. Honda, Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, and A. Takaoka Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction Nature 434 2005 1035 1040
60. Q.Q. Huang, and R.M. Pope The role of Toll-like receptors in rheumatoid arthritis Curr Rheumatol Rep 11 2009 357 364
61. J.M. Ireland, and E.R. Unanue Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells J Exp Med 208 2011 2625 2632
62. E.S. Izmailova, N. Paz, H. Alencar, M. Chun, L. Schopf, and M. Hepperle Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis Arthritis Rheum 56 2007 117 128
63. D.L. Jacobson, S.J. Gange, N.R. Rose, and N.M. Graham Epidemiology and estimated population burden of selected autoimmune diseases in the United States Clin Immunol Immunopathol 84 1997 223 243
64. G.B. Johnson, G.J. Brunn, Y. Kodaira, and J.L. Platt Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4 J Immunol 168 2002 5233 5239
65. L.A. Joosten, M.I. Koenders, R.L. Smeets, M. Heuvelmans-Jacobs, M.M. Helsen, and K. Takeda Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88 J Immunol 171 2003 6145 6153
66. N. Kanarek, and Y. Ben-Neriah Regulation of NF-kappaB by ubiquitination and degradation of the IkappaBs Immunol Rev 246 2012 77 94
67. A. Kawakami, K. Nakashima, M. Tamai, H. Nakamura, N. Iwanaga, and K. Fujikawa Toll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line J Rheumatol 34 2007 1019 1026
68. T. Kawamoto, M. Ii, T. Kitazaki, Y. Iizawa, and H. Kimura TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain Eur J Pharmacol 584 2008 40 48
69. D. Kim, A. Peck, D. Santer, P. Patole, S.M. Schwartz, and J.A. Molitor Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis Arthritis Rheum 58 2008 2163 2173
70. W.U. Kim, A. Sreih, and R. Bucala Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention Autoimmun Rev 8 2009 204 208
71. N. Kishore, C. Sommers, S. Mathialagan, J. Guzova, M. Yao, and S. Hauser A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts J Biol Chem 278 2003 32861 32871
72. K. Kruse, C. Janko, V. Urbonaviciute, C.T. Mierke, T.H. Winkler, and R.E. Voll Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players Apoptosis 15 2010 1098 1113
73. K. Kucera, A.A. Koblansky, L.P. Saunders, K.B. Frederick, E.M. De La Cruz, and S. Ghosh Structure-based analysis of Toxoplasma gondii profilin: a parasite-specific motif is required for recognition by Toll-like receptor 11 J Mol Biol 403 2010 616 629
74. O.P. Kulkarni, M. Ryu, C. Kantner, M. Sardy, D. Naylor, and D. Lambert Recombinant chaperonin 10 suppresses cutaneous lupus and lupus nephritis in MRL-(Fas)lpr mice Nephrol Dial Transplant 27 2012 1358 1367
75. M.V. Kumar, C.N. Nagineni, M.S. Chin, J.J. Hooks, and B. Detrick Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells J Neuroimmunol 153 2004 7 15
76. E.A. Kurt-Jones, L. Popova, L. Kwinn, L.M. Haynes, L.P. Jones, and R.A. Tripp Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus Nat Immunol 1 2000 398 401
77. S.K. Kwok, M.L. Cho, Y.M. Her, H.J. Oh, M.K. Park, and S.Y. Lee TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome Arthritis Res Ther 14 2012 R64
78. D. Kyburz, F. Brentano, and S. Gay Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling Nat Clin Pract Rheumatol 2 2006 458 459
79. R. Lafyatis, and M. York Innate immunity and inflammation in systemic sclerosis Curr Opin Rheumatol 21 2009 617 622
80. A. Lanzavecchia, and F. Sallusto Toll-like receptors and innate immunity in B-cell activation and antibody responses Curr Opin Immunol 19 2007 268 274
81. A. Lartigue, N. Colliou, S. Calbo, A. Francois, S. Jacquot, and C. Arnoult Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus J Immunol 183 2009 6207 6216
82. A. Lartigue, P. Courville, I. Auquit, A. Francois, C. Arnoult, and F. Tron Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus J Immunol 177 2006 1349 1354
83. E. Latz, A. Verma, A. Visintin, M. Gong, C.M. Sirois, and D.C. Klein Ligand-induced conformational changes allosterically activate Toll-like receptor 9 Nat Immunol 8 2007 772 779
84. C.M. Lau, C. Broughton, A.S. Tabor, S. Akira, R.A. Flavell, and M.J. Mamula RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement J Exp Med 202 2005 1171 1177
85. E.A. Leadbetter, I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, and A. Marshak-Rothstein Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors Nature 416 2002 603 607
86. J. Lee, T.H. Chuang, V. Redecke, L. She, P.M. Pitha, and D.A. Carson Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7 Proc Natl Acad Sci USA 100 2003 6646 6651
87. X.D. Li, and Z.J. Chen Sequence specific detection of bacterial 23S ribosomal RNA by TLR13 elife 1 2012 e00102
88. B. Liu, Y. Yang, J. Dai, R. Medzhitov, M.A. Freudenberg, and P.L. Zhang TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease J Immunol 177 2006 6880 6888
89. W. Liu, B.R. Deyoung, X. Chen, D.P. Evanoff, and Y. Luo RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model J Autoimmun 30 2008 257 265
90. Z.Q. Liu, G.M. Deng, S. Foster, and A. Tarkowski Staphylococcal peptidoglycans induce arthritis Arthritis Res 3 2001 375 380
91. T. Lovgren, M.L. Eloranta, B. Kastner, M. Wahren-Herlenius, G.V. Alm, and L. Ronnblom Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA Arthritis Rheum 54 2006 1917 1927
92. K. Lundberg, N. Wegner, T. Yucel-Lindberg, and P.J. Venables Periodontitis in RA-the citrullinated enolase connection Nat Rev Rheumatol 6 2010 727 730
93. P. Luppi How immune mechanisms are affected by pregnancy Vaccine 21 2003 3352 3357
94. M.N. Manoussakis, M.P. Spachidou, and C.I. Maratheftis Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation J Autoimmun 35 2010 212 218
95. A. Marshak-Rothstein Toll-like receptors in systemic autoimmune disease Nat Rev Immunol 6 2006 823 835
96. P. Massari, P. Henneke, Y. Ho, E. Latz, D.T. Golenbock, and L.M. Wetzler Cutting edge: immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent J Immunol 168 2002 1533 1537
97. G. Mbalaviele, C.D. Sommers, S.L. Bonar, S. Mathialagan, J.F. Schindler, and J.A. Guzova A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models J Pharmacol Exp Ther 329 2009 14 25
98. C.E. McCoy, and L.A. O'Neill The role of Toll-like receptors in macrophages Front Biosci 13 2008 62 70
99. T.K. Means, E. Latz, F. Hayashi, M.R. Murali, D.T. Golenbock, and A.D. Luster Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9 J Clin Invest 115 2005 407 417
100. T.K. Means, S. Wang, E. Lien, A. Yoshimura, D.T. Golenbock, and M.J. Fenton Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis J Immunol 163 1999 3920 3927
101. L. Meng, W. Zhu, C. Jiang, X. He, W. Hou, and F. Zheng Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats Arthritis Res Ther 12 2010 R103
102. A. Meyer-Bahlburg, and D.J. Rawlings B cell autonomous TLR signaling and autoimmunity Autoimmun Rev 7 2008 313 316
103. K.H. Mills TLR-dependent T cell activation in autoimmunity Nat Rev Immunol 11 2011 807 822
104. M. Nakamura, Y. Shimizu, Y. Sato, Y. Miyazaki, T. Satoh, and M. Mizuno Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice Eur J Pharmacol 569 2007 237 243
105. G. Napolitani, A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells Nat Immunol 6 2005 769 776
106. P.N. Nelson, G.M. Reynolds, E.E. Waldron, E. Ward, K. Giannopoulos, and P.G. Murray Monoclonal antibodies Mol Pathol 53 2000 111 117
107. R. Newton, N.S. Holden, M.C. Catley, W. Oyelusi, R. Leigh, and D. Proud Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors J Pharmacol Exp Ther 321 2007 734 742
108. L.A. O'Neill, and A.G. Bowie The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling Nat Rev Immunol 7 2007 353 364
109. L.A. O'Neill, K.A. Fitzgerald, and A.G. Bowie The Toll-IL-1 receptor adaptor family grows to five members Trends Immunol 24 2003 286 290
110. K. Ohashi, V. Burkart, S. Flohe, and H. Kolb Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex J Immunol 164 2000 558 561
111. Y. Okamura, M. Watari, E.S. Jerud, D.W. Young, S.T. Ishizaka, and J. Rose The extra domain A of fibronectin activates Toll-like receptor 4 J Biol Chem 276 2001 10229 10233
112. M. Oldenburg, A. Kruger, R. Ferstl, A. Kaufmann, G. Nees, and A. Sigmund TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification Science 337 2012 1111 1115
113. B. Opitz, N.W. Schroder, I. Spreitzer, K.S. Michelsen, C.J. Kirschning, and W. Hallatschek Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation J Biol Chem 276 2001 22041 22047
114. A. Ozinsky, D.M. Underhill, J.D. Fontenot, A.M. Hajjar, K.D. Smith, and C.B. Wilson The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors Proc Natl Acad Sci USA 97 2000 13766 13771
115. J.S. Park, D. Svetkauskaite, Q. He, J.Y. Kim, D. Strassheim, and A. Ishizaka Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370 7377
116. P.S. Patole, H.J. Grone, S. Segerer, R. Ciubar, E. Belemezova, and A. Henger Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells J Am Soc Nephrol 16 2005 1326 1338
117. M. Pierer, J. Rethage, R. Seibl, R. Lauener, F. Brentano, and U. Wagner Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands J Immunol 172 2004 1256 1265
118. A. Poltorak, X. He, I. Smirnova, M.Y. Liu, C. Van Huffel, and X. Du Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
119. T.R. Radstake, M.F. Roelofs, Y.M. Jenniskens, B. Oppers-Walgreen, P.L. van Riel, and P. Barrera Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma Arthritis Rheum 50 2004 3856 3865
120. C.T. Ranjith-Kumar, K.E. Duffy, J.L. Jordan, A. Eaton-Bassiri, R. Vaughan, and S.A. Hoose Single-stranded oligonucleotides can inhibit cytokine production induced by human Toll-like receptor 3 Mol Cell Biol 28 2008 4507 4519
121. T. Rashid, and A. Ebringer Rheumatoid arthritis is linked to Proteus - the evidence Clin Rheumatol 26 2007 1036 1043
122. J.C. Rassa, J.L. Meyers, Y. Zhang, R. Kudaravalli, and S.R. Ross Murine retroviruses activate B cells via interaction with Toll-like receptor 4 Proc Natl Acad Sci USA 99 2002 2281 2286
123. C. Reis e Sousa Toll-like receptors and dendritic cells: for whom the bug tolls Semin Immunol 16 2004 27 34
124. M.F. Roelofs, S. Abdollahi-Roodsaz, L.A. Joosten, W.B. van den Berg, and T.R. Radstake The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions Arthritis Rheum 58 2008 338 348
125. M.F. Roelofs, L.A. Joosten, S. Abdollahi-Roodsaz, A.W. van Lieshout, T. Sprong, and F.H. van den Hoogen The expression of Toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of Toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells Arthritis Rheum 52 2005 2313 2322
126. M.F. Roelofs, M.H. Wenink, F. Brentano, S. Abdollahi-Roodsaz, B. Oppers-Walgreen, and P. Barrera Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA) Ann Rheum Dis 68 2009 1486 1493
127. T. Roger, C. Froidevaux, D. Le Roy, M.K. Reymond, A.L. Chanson, and D. Mauri Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4 Proc Natl Acad Sci USA 106 2009 2348 2352
128. E. Romano, M. Manetti, S. Guiducci, C. Ceccarelli, Y. Allanore, and M. Matucci-Cerinic The genetics of systemic sclerosis: an update Clin Exp Rheumatol 29 2011 S75 S86
129. L. Ronnblom, M.L. Eloranta, and G.V. Alm The type I interferon system in systemic lupus erythematosus Arthritis Rheum 54 2006 408 420
130. M. Rutz, J. Metzger, T. Gellert, P. Luppa, G.B. Lipford, and H. Wagner Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner Eur J Immunol 34 2004 2541 2550
131. S.M. Sacre, A. Lo, B. Gregory, R.E. Simmonds, L. Williams, and M. Feldmann Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures J Immunol 181 2008 8002 8009
132. E. Savarese, O.W. Chae, S. Trowitzsch, G. Weber, B. Kastner, and S. Akira U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7 Blood 107 2006 3229 3234
133. L. Schopf, A. Savinainen, K. Anderson, J. Kujawa, M. DuPont, and M. Silva IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis Arthritis Rheum 54 2006 3163 3173
134. R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C.J. Kirschning Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2 J Biol Chem 274 1999 17406 17409
135. R. Seibl, T. Birchler, S. Loeliger, J.P. Hossle, R.E. Gay, and T. Saurenmann Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium Am J Pathol 162 2003 1221 1227
136. M.J. Shlomchik Activating systemic autoimmunity: B's, T's, and tolls Curr Opin Immunol 21 2009 626 633
137. S.T. Smiley, J.A. King, and W.W. Hancock Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4 J Immunol 167 2001 2887 2894
138. J. Sokolove, X. Zhao, P.E. Chandra, and W.H. Robinson Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor Arthritis Rheum 63 2011 53 62
139. M.P. Spachidou, E. Bourazopoulou, C.I. Maratheftis, E.K. Kapsogeorgou, H.M. Moutsopoulos, and A.G. Tzioufas Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome Clin Exp Immunol 147 2007 497 503
140. S. Subramanian, K. Tus, Q.Z. Li, A. Wang, X.H. Tian, and J. Zhou A Tlr7 translocation accelerates systemic autoimmunity in murine lupus Proc Natl Acad Sci USA 103 2006 9970 9975
141. J. Tabiasco, E. Devevre, N. Rufer, B. Salaun, J.C. Cerottini, and D. Speiser Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor J Immunol 177 2006 8708 8713
142. O. Takeuchi, K. Hoshino, T. Kawai, H. Sanjo, H. Takada, and T. Ogawa Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components Immunity 11 1999 443 451
143. O. Takeuchi, T. Kawai, P.F. Muhlradt, M. Morr, J.D. Radolf, and A. Zychlinsky Discrimination of bacterial lipoproteins by Toll-like receptor 6 Int Immunol 13 2001 933 940
144. O. Takeuchi, S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, and Z. Dong Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins J Immunol 169 2002 10 14
145. Y. Tamaki, Y. Takakubo, T. Hirayama, Y.T. Konttinen, S.B. Goodman, and M. Yamakawa Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis J Rheumatol 38 2011 810 820
146. K. Tao, M. Fujii, S. Tsukumo, Y. Maekawa, K. Kishihara, and Y. Kimoto Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population Ann Rheum Dis 66 2007 905 909
147. I.O. Tassiulas, and D.T. Boumpas Clinical features and treatment of systemic lupus erythematosus G.S. Firestein, R.C. Budd, E.D. Harris Jr. I.B. McInnes, S. Ruddy, J.S. Sergent, Kelley's Textbook of Rheumatology 8th ed. 2008
148. C. Termeer, F. Benedix, J. Sleeman, C. Fieber, U. Voith, and T. Ahrens Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4 J Exp Med 195 2002 99 111
149. M. Tidswell, W. Tillis, S.P. Larosa, M. Lynn, A.E. Wittek, and R. Kao Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis Crit Care Med 38 2010 72 83
150. S. Travis, L.M. Yap, C. Hawkey, B. Warren, M. Lazarov, and T. Fong RDP58 is a novel and potentially effective oral therapy for ulcerative colitis Inflamm Bowel Dis 11 2005 713 719
151. D.M. Underhill, A. Ozinsky, A.M. Hajjar, A. Stevens, C.B. Wilson, and M. Bassetti The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens Nature 401 1999 811 815
152. R. Ungaro, M. Fukata, D. Hsu, Y. Hernandez, K. Breglio, and A. Chen A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis Am J Physiol Gastrointest Liver Physiol 296 2009 G1167 G1179
153. R.M. Vabulas, P. Ahmad-Nejad, S. Ghose, C.J. Kirschning, R.D. Issels, and H. Wagner HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway J Biol Chem 277 2002 15107 15112
154. L. van Bon, C. Popa, R. Huijbens, M. Vonk, M. York, and R. Simms Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis Ann Rheum Dis 69 2010 1539 1547
155. A.W. van Lieshout, M.C. Vonk, S.J. Bredie, L.B. Joosten, M.G. Netea, and P.L. van Riel Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion Scand J Rheumatol 38 2009 282 290
156. D. Vanags, B. Williams, B. Johnson, S. Hall, P. Nash, and A. Taylor Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial Lancet 368 2006 855 863
157. J. Varga, and C.P. Denton Systemic sclerosis and the scleroderma-spectrum disorders G.S. Firestein, R.C. Budd, E.D. Harris Jr. I.B. McInnes, S. Ruddy, J.S. Sergent, Kelley's Textbook of Rheumatology 8th ed. 2008
158. J. Vollmer, S. Tluk, C. Schmitz, S. Hamm, M. Jurk, and A. Forsbach Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 J Exp Med 202 2005 1575 1585
159. C. Werts, R.I. Tapping, J.C. Mathison, T.H. Chuang, V. Kravchenko, and I. Saint Girons Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism Nat Immunol 2 2001 346 352
160. X. Wu, and S.L. Peng Toll-like receptor 9 signaling protects against murine lupus Arthritis Rheum 54 2006 336 342
161. D.H. Wyllie, E. Kiss-Toth, A. Visintin, S.C. Smith, S. Boussouf, and D.M. Segal Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses J Immunol 165 2000 7125 7132
162. K. Yasuda, C. Richez, M.B. Uccellini, R.J. Richards, R.G. Bonegio, and S. Akira Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes J Immunol 183 2009 3109 3117
163. A. Yoshizaki, K. Komura, Y. Iwata, F. Ogawa, T. Hara, and E. Muroi Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity J Clin Immunol 29 2009 180 189
164. M. Yu, H. Wang, A. Ding, D.T. Golenbock, E. Latz, and C.J. Czura HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2 Shock 26 2006 174 179
165. P. Yu, U. Wellmann, S. Kunder, L. Quintanilla-Martinez, L. Jennen, and N. Dear Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE Int Immunol 18 2006 1211 1219
166. X. Yu, B. Song, C. Huang, Y. Xiao, M. Fang, and J. Feng Prolonged survival time of allografts by the oral administration of RDP58 linked to the cholera toxin B subunit Transpl Immunol 27 2012 122 127
167. R.A. Zeuner, K.J. Ishii, M.J. Lizak, I. Gursel, H. Yamada, and D.M. Klinman Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides Arthritis Rheum 46 2002 2219 2224
168. D. Zhang, G. Zhang, M.S. Hayden, M.B. Greenblatt, C. Bussey, and R.A. Flavell A Toll-like receptor that prevents infection by uropathogenic bacteria Science 303 2004 1522 1526
169. L. Zheng, Z. Zhang, C. Yu, and C. Yang Expression of Toll-like receptors 7, 8, and 9 in primary Sjogren's syndrome Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109 2010 844 850